These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 37895898)

  • 21. Insights into the role of dopamine receptor systems in learning and memory.
    El-Ghundi M; O'Dowd BF; George SR
    Rev Neurosci; 2007; 18(1):37-66. PubMed ID: 17405450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine signaling in reward-related behaviors.
    Baik JH
    Front Neural Circuits; 2013; 7():152. PubMed ID: 24130517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine receptor pharmacology: interactions with serotonin receptors and significance for the aetiology and treatment of schizophrenia.
    Werkman TR; Glennon JC; Wadman WJ; McCreary AC
    CNS Neurol Disord Drug Targets; 2006 Feb; 5(1):3-23. PubMed ID: 16613551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice.
    Mercuri NB; Saiardi A; Bonci A; Picetti R; Calabresi P; Bernardi G; Borrelli E
    Neuroscience; 1997 Jul; 79(2):323-7. PubMed ID: 9200717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.
    Alex KD; Pehek EA
    Pharmacol Ther; 2007 Feb; 113(2):296-320. PubMed ID: 17049611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heteromerization of dopaminergic receptors in the brain: Pharmacological implications.
    Misganaw D
    Pharmacol Res; 2021 Aug; 170():105600. PubMed ID: 33836279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease.
    Borroto-Escuela DO; Carlsson J; Ambrogini P; Narváez M; Wydra K; Tarakanov AO; Li X; Millón C; Ferraro L; Cuppini R; Tanganelli S; Liu F; Filip M; Diaz-Cabiale Z; Fuxe K
    Front Cell Neurosci; 2017; 11():37. PubMed ID: 28270751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic signaling in dendritic spines.
    Yao WD; Spealman RD; Zhang J
    Biochem Pharmacol; 2008 Jun; 75(11):2055-69. PubMed ID: 18353279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopaminergic Modulation of Synaptic Plasticity, Its Role in Neuropsychiatric Disorders, and Its Computational Modeling.
    Madadi Asl M; Vahabie AH; Valizadeh A
    Basic Clin Neurosci; 2019; 10(1):1-12. PubMed ID: 31031889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circadian control of BDNF-mediated Nrf2 activation in astrocytes protects dopaminergic neurons from ferroptosis.
    Ishii T; Warabi E; Mann GE
    Free Radic Biol Med; 2019 Mar; 133():169-178. PubMed ID: 30189266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases.
    Walaas SI; Hemmings HC; Greengard P; Nairn AC
    Front Neuroanat; 2011; 5():50. PubMed ID: 21904525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The heterotetrameric structure of the adenosine A
    Cortés A; Casadó-Anguera V; Moreno E; Casadó V
    Adv Pharmacol; 2019; 84():37-78. PubMed ID: 31229177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine: Functions, Signaling, and Association with Neurological Diseases.
    Klein MO; Battagello DS; Cardoso AR; Hauser DN; Bittencourt JC; Correa RG
    Cell Mol Neurobiol; 2019 Jan; 39(1):31-59. PubMed ID: 30446950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of Pedunculopontine Glutamate Neurons Is Reinforcing.
    Yoo JH; Zell V; Wu J; Punta C; Ramajayam N; Shen X; Faget L; Lilascharoen V; Lim BK; Hnasko TS
    J Neurosci; 2017 Jan; 37(1):38-46. PubMed ID: 28053028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G protein-coupled receptor kinases as regulators of dopamine receptor functions.
    Gurevich EV; Gainetdinov RR; Gurevich VV
    Pharmacol Res; 2016 Sep; 111():1-16. PubMed ID: 27178731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The modulatory role of dopamine receptors in brain neuroinflammation.
    Xia QP; Cheng ZY; He L
    Int Immunopharmacol; 2019 Nov; 76():105908. PubMed ID: 31622861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology.
    Fuxe K; Marcellino D; Rivera A; Diaz-Cabiale Z; Filip M; Gago B; Roberts DC; Langel U; Genedani S; Ferraro L; de la Calle A; Narvaez J; Tanganelli S; Woods A; Agnati LF
    Brain Res Rev; 2008 Aug; 58(2):415-52. PubMed ID: 18222544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Signaling and Pharmacology of the Dopamine D1 Receptor.
    Jones-Tabah J; Mohammad H; Paulus EG; Clarke PBS; Hébert TE
    Front Cell Neurosci; 2021; 15():806618. PubMed ID: 35110997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine D1 receptor agonism induces dynamin related protein-1 inhibition to improve mitochondrial biogenesis and dopaminergic neurogenesis in rat model of Parkinson's disease.
    Mishra A; Singh S; Tiwari V; Bano S; Shukla S
    Behav Brain Res; 2020 Jan; 378():112304. PubMed ID: 31626851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation.
    Kibret BG; Canseco-Alba A; Onaivi ES; Engidawork E
    Front Behav Neurosci; 2023; 17():1137957. PubMed ID: 37009000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.